Health Care/Hospital

Miroma Project Factory: Powers Clinical-Grade App for One of Australia's Largest Smoking Cessation Trials

SYDNEY, Dec. 16, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of the International Lung Study trial and one of Australia's most ambitious research studies targeting smoking cessation in people ...

2025-12-16 05:07 1705

PM-International expands child sponsorships to 8,000 with €2.88 million donation

SCHENGEN, Luxembourg, Dec. 15, 2025 /PRNewswire/ -- Global support for children in need is declining rapidly. According to World Vision, governments and institutions worldwide have cut funding for children's aid by$16.3 billion, limiting access to food, healthcare and education for millions of vu...

2025-12-15 22:13 1521

NYSE Content Advisory: Pre-Market Update + Seven of the Top 10 IPOs in 2025 List on NYSE

NEW YORK, Dec. 15, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on December 15th ...

2025-12-15 22:10 2864

Rona Therapeutics Advances INHBE siRNA Into Phase 1 Clinical Development

SHANGHAI and SANTA BARBARA, Calif., Dec. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a clinical-stage RNAi company, today announced the recent completion of Cohort 1 dosing in its Phase 1 first-in-human clinical study of RN3161, an investigational GalNAc-conjugated siRNA targeting INHBE for obesit...

2025-12-15 21:00 2328

Curie Oncology and Oncoshot Deploy AI to Improve Patient Outcomes in Asia

SINGAPORE, Dec. 15, 2025 /PRNewswire/ -- Curie Oncology, one of Southeast Asia's fastest-growing private oncology networks, has partnered withSingapore-based health-tech company Oncoshot to deploy AI-powered clinical research tools that help patients gain faster access to clinical trials.

2025-12-15 19:26 2174

MEDEZE Receives Frost & Sullivan's 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine

The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence acrossSoutheast Asia SAN ANTONIO, Dec. 15, 2025 /PRNewswire/ -- Frost & Sullivan

2025-12-15 17:00 1630

Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

-  The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once-daily or potentially once-weekly oral dosing. -  ASC50 had strong target engagement after a single oral dose, in...

2025-12-15 17:00 4179

Global Spotlight|POGMENT Biomimetic Collagen "Stable Triple Helix" Breakthrough Stuns the World--Extraordinary and Breathtaking

CHENGDU, China, Dec. 15, 2025 /PRNewswire/ -- Recently, LivingPhoenix Regenerative Technologies has captured widespread attention with its world-first "Stable Triple-Helix Biomimetic Collagen" technology, making consecutive appearances at 12 high-level academic conferences in November. These eve...

2025-12-15 16:32 1482

Medit Announces 2025 Year-End Promotion

SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- Medit, a global leader in 3D dental scanning solutions, announced the launch of "Medit's 2025 End of Year Promotion," a limited-time campaign delivering significant benefits to dental professionals worldwide. Dental professionals can learn more ab...

2025-12-15 16:00 2016

DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT

* Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient * The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in combination with standard-of-care blood pressu...

2025-12-15 15:02 1364

Manulife and Bupa Sign MoU for Strategic Collaboration in Hong Kong to Create a More Robust, Integrated Healthcare Network Offering Customers Greater Access and Choice

HONG KONG, Dec. 15, 2025 /PRNewswire/ -- Manulife (International) Limited ("Manulife") and Bupa International Limited ("Bupa") are pleased to announce today the signing of a Memorandum of Understanding ("MoU"), intended to establish a strategic collaboration inHong Kong that will provide customer...

2025-12-15 13:45 2560

Everest Medicines Announces 2030 Strategy and Increase in Shareholdings by Directors and Substantial Shareholder

SHANGHAI, Dec. 15, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the launch of its 2030 Strategy, out...

2025-12-15 12:40 1875

AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List

SINGAPORE, Dec. 15, 2025 /PRNewswire/ -- AbbVie ASEAN has been ranked #15 in the inauguralFortune Best Companies to Work For Southeast Asia 2025 list, in partnership with Great Place To Work®, highlighting workplaces acrossSingapore, Malaysia, Thailand and the Philippines.

2025-12-15 09:00 3810

Patient Enrolment Completed in Phase 2 aGvHD Clinical Trial

Announcement Highlights: * Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease. * The study has enrolled a total of 65 participants in the US, Europe and Australia, each of whom was randomised to receive either steroids plus CY...

2025-12-15 08:25 1655

ALL CONEC Signs MOU with MINIMAX to Accelerate Global Digital Dental Expansion

SEOUL, South Korea, Dec. 13, 2025 /PRNewswire/ -- ALL CONEC has signed a memorandum of understanding (MOU) with Australian digital dental company MINIMAX to jointly promote digital implant production, marking a strategic move to expand into global markets. The collaboration will validate implant...

2025-12-13 08:00 2898

Leaders Dental Strengthens Global Competitiveness With CAD/CAM-Based Digital Prosthetics Technology

SEOUL, South Korea, Dec. 12, 2025 /PRNewswire/ -- As the global CAD/CAM-based digital prosthetics market continues to grow rapidly, the importance of laboratories equipped with advanced automation and precision manufacturing capabilities is rising. Leaders Dental Laboratory is enhancing its comp...

2025-12-12 08:00 1130

MINDS' Inclusive DIY Christmas Socks by SPED Students Go on Display at Fernvale CC

SINGAPORE, Dec. 12, 2025 /PRNewswire/ -- The Lions Club of Singapore Lotusia, in collaboration with MINDS Raintree Special Student Care Centre (SSCC), hosted "Little Hands, Big Joy", a Christmas celebration designed to bring joy, warmth and meaningful connection to 29 students with intellectual d...

2025-12-12 07:18 1672

TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally

TraceLink announced its support for UNICEF's Traceability and Verification System (TRVST), a global initiative improving the safety, authenticity, and traceability of medicines in regions vulnerable to falsified or substandard products. By supporting TRVST, TraceLink reinforces its position as th...

2025-12-12 00:21 2727

Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix®

CONSHOHOCKEN, Pa., Dec. 11, 2025 /PRNewswire/ -- Suvoda, a global clinical trial technology company, today announced that its IRT (Interactive Response Technology) software, also known as RTSM (Randomization and Trial Supply Management), has been recognized as aLeader in Everest Group's PEAK Matr...

2025-12-12 00:00 1426

Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten

- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease  leveraging Everest's existing commercial organization - Exclusive Greater China license to develop and commercialize Lerodalcibep, a novel, small protein-bindin...

2025-12-11 23:57 1980
1234567 ... 551

Week's Top Stories